In acute ischemic stroke, adding minocycline to standard care increased excellent functional outcome rates at 90 d

Key Points

• To evaluate the impact of minocycline on functional outcomes in patients with acute ischemic stroke.
• Randomized trial design
• Comparison of minocycline plus standard care vs. standard care alone
• Follow-up at 90 days to assess outcomes.
• Minocycline group had higher rates of excellent functional outcomes at 90 days compared to the control group.